abstract |
The invention relates to chemical compounds of formula (I) or a pharmaceutically acceptable salt thereof, as defined herein, to pharmaceutical compositions and to their use in the treatment of conditions or disorders mediated by TNF-α or PDE4, including, but not limited to, rheumatoid arthritis. |